: How life sciences innovation survives uncertainty with investor Leen Limbourg

Drawing on her experience across investment funds and healthtech, Leen shares how founders can navigate complexity while continuing to innovate at the intersection of science, technology and entrepreneurship.

Key topics discussed in this episode include:

• How life sciences companies deal with geopolitical uncertainty and slower capital flows
• The impact of European regulation on innovation and competitiveness
• Why the funding environment remains difficult and what founders can realistically expect
• The growing role of AI in healthcare, and where human judgment remains essential
• The importance of strong governance, boards and investor–founder alignment

This conversation offers a grounded and practical perspective on what it takes to build reselient companies in times of uncertainty, and why thoughtful leadership and long-term thinking are decisive advantages in the life sciences sector.